Literature DB >> 23785997

[Determination of four alkaloids in compound Kushen Injection by high performance liquid chromatography with ionic liquid as mobile phase additive].

Liang Qi1, Jing Zhang, Zhiqi Zhang.   

Abstract

In order to improve the resolution and peak shape, 1-butyl-3-methylimidazolium tetrafluoroborate ( [ BMIM] BF4 ) was used as mobile phase additive to develop an HPLC method for the determination of four main alkaloids in Compound Kushen Injection. An Agilent TC-C18 column was used with the mobile phase of methanol-0.1% phosphoric acid solution (containing 2. 2 x 10(4) mol/L [BMIM] BF4 ) (5: 95, v/v) , flow rate of 1.0 mL/min, column temperature of 30 degree C, and injection volume of 20 micro L, detected at 205 nm. The calibration curves of matrine, sophoridine, oxymatrine and oxysophocarpine were in good linearity over the ranges of 25.8 -155.0 mg/L, 40.0 -240.0 mg/L, 21.7 - 130.0 mg/L and 37.5 -225.0 mg/L, respectively, with correlation coefficients above 0. 999 0. The mean recoveries (n = 9) were between 96. 2% and 98.9%. Ionic liquid, [BMIM] BF4, can obviously improve the resolution and peak shape. The method is simple, rapid, and reliable, and can be used for the determination of alkaloids in Sophora flavescens Ait in Compound Kushen Injection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23785997     DOI: 10.3724/sp.j.1123.2012.10039

Source DB:  PubMed          Journal:  Se Pu        ISSN: 1000-8713


  8 in total

1.  Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.

Authors:  Chongwen Bi; Caixia Zhang; Yinghong Li; Sheng Tang; Shenggang Wang; Rongguang Shao; Haigen Fu; Feng Su; Danqing Song
Journal:  ACS Med Chem Lett       Date:  2014-09-22       Impact factor: 4.345

Review 2.  Anti-tumor activities of active ingredients in Compound Kushen Injection.

Authors:  Wei Wang; Rong-li You; Wen-jie Qin; Li-na Hai; Ming-jing Fang; Guo-hua Huang; Rui-xia Kang; Ming-hua Li; Yu-feng Qiao; Jian-wei Li; An-ping Li
Journal:  Acta Pharmacol Sin       Date:  2015-05-18       Impact factor: 6.150

Review 3.  Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges.

Authors:  Kexin Li; Kunmin Xiao; Shijie Zhu; Yong Wang; Wei Wang
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

4.  Compound Radix Sophorae Flavescentis exerts antitumor effects by inhibiting the proliferation and inducing the apoptosis of esophageal carcinoma TE-8 cells.

Authors:  Xiaoyu Yang; Weimei Cai; Qinghui Yang; Zhihong Lu; Jinsong Li; Jian Yu
Journal:  Oncol Lett       Date:  2015-08-13       Impact factor: 2.967

5.  Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia.

Authors:  Honglei Tu; Bo Lei; Shan Meng; Hailing Liu; Yongchang Wei; Aili He; Wanggang Zhang; Fuling Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-21       Impact factor: 2.629

Review 6.  Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Lixiu Yu; Ying Zhou; Yu Yang; Furong Lu; Yeqin Fan
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-12       Impact factor: 2.629

Review 7.  Research Progress in the Pharmacological Activities, Toxicities, and Pharmacokinetics of Sophoridine and Its Derivatives.

Authors:  Qiong Tang; Yao Liu; Xi Peng; Baojun Wang; Fei Luan; Nan Zeng
Journal:  Drug Des Devel Ther       Date:  2022-01-18       Impact factor: 4.162

8.  A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer.

Authors:  Yi Li; Kexin Wang; Yupeng Chen; Jieqi Cai; Xuemei Qin; Aiping Lu; Daogang Guan; Genggeng Qin; Weiguo Chen
Journal:  Front Pharmacol       Date:  2021-11-16       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.